ORF K14HHV8 (AA 111-210) Antikörper (Alexa Fluor 555)
-
- Target
- ORF K14HHV8
- Bindungsspezifität
- AA 111-210
- Reaktivität
- Human Herpesvirus 8 (HHV-8), Virus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Alexa Fluor 555
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Virus
- Kreuzreaktivität (Details)
- HHV 8 type M
- Produktmerkmale
- Antibody is specific for: HHV 8 type M
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human HHV8/ORF K14
- Isotyp
- IgG
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- ORF K14HHV8
- Substanzklasse
- Viral Protein
- Hintergrund
-
Synonyms: NULL
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
-